Recombinant Human KGF/FGF-7 Protein, CF

R&D Systems | Catalog # 11537-KG

CHO expressed
R&D Systems
100% Guarantee

Key Product Details

  • R&D Systems CHO-derived Recombinant Human KGF/FGF-7 Protein (11537-KG)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

CHO

Accession Number

P21781.1

Applications

Bioactivity
View all KGF/FGF-7 Proteins and Enzymes »

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human KGF/FGF-7 protein
Ser55-Thr194

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Ser55

Predicted Molecular Mass

16 kDa

SDS-PAGE

15-18 kDa, under reducing conditions

Activity

Measured in a cell proliferation assay using Ba/F3 mouse pro B cells transfected with human FGF RIIb. The ED50 for this effect is 4.00‑40.0 ng/mL.

Scientific Data Images for Recombinant Human KGF/FGF-7 Protein, CF

Recombinant Human KGF/FGF‑7 Protein Bioactivity.

Measured in a cell proliferation assay using Ba/F3 mouse pro B cells transfected with human FGF RIIb. The ED50 for this effect is 4.00-40.0 ng/mL.

Recombinant Human KGF/FGF‑7 Protein SDS-PAGE.

2 μg/lane of Recombinant Human KGF/FGF‑7 Protein (Catalog # 11537-KG) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 15-18 kDa, under reducing conditions.

Formulation, Preparation, and Storage

11537-KG
Formulation Lyophilized from a 0.2 μm filtered solution in MOPS, Na2SO4 and EDTA with Trehalose.
Reconstitution Reconstitute 10 μg size at 100 μg/mL and the other sizes at 200 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: KGF/FGF-7

Fibroblast growth factor 7 (FGF7), also known as keratinocyte growth factor (KGF), is a member of the FGF family of secreted glycoproteins which are involved in key roles from development, morphogenesis, and angiogenesis to wound healing and tumorigenesis (1-4). FGF7, along with FGF3, FGF10, and FGF22, form a subfamily of the larger FGF family whose expression is restricted to cells of mesenchymal origin and function as paracrine growth factors for nearby epithelial cells (1). The FGF family is characterized by a core heparin-binding FGF domain of approximately 120 amino acids (aa) that exhibits a conserved beta -trefoil structure (2). Mature human FGF7 shares 96% and 92% aa sequence identity with mouse and rat FGF7, respectively. FGF7 signals only through the IIIb splice form of the receptor FGFR2, whose expression is restricted primarily to epithelial cells (5). FGF7 is noticeably upregulated in response to damage to skin or internal structures and is proposed to help speed-up wound healing (6). Deletion of FGF7 affects kidney development, producing abnormally small ureteric buds and fewer nephrons (7). FGF7 has been proposed as a potential cancer therapeutic by targeting the intermolecular interaction site between FGF7 and FGFR2b (3). Additionally, the use of FGF7 is being explored as novel treatment options for cartilage diseases, such as Osteoarthritis and Rheumatoid arthritis (8). An N-terminally truncated version of FGF7 with improved thermal stability, named Palifermin (brand name Kepivance), is approved for treatment for reducing and/or healing damages caused by cancer chemotherapy and radiotherapy, such as severe oral mucositis (OM) (9,10).

References

  1. Mohammadi, M. et al. (2005) Cytokine Growth Factor Rev. 16:107.
  2. Itoh, N. and D.M. Ornitz (2008) Dev. Dyn. 237:18.
  3. Vadija, R. et al. (2016) J. Chem. Biol. 9:69.
  4. Itoh, N. and D.M. Ornitz (2004). Trends Genet. 20:563.
  5. Steiling, H. and S. Werner (2003) Curr. Opin. Biotechnol. 14:533.
  6. Geer, D.J. et al. (2005) Am. J. Pathol. 167:1575.
  7. Qiao, J. et al. (1999) Development 126:547.
  8. Zhang, X. et al. (2023) Life Sci. 326:121804.
  9. Hsu, E. et al. (2006) PEDS 19:147.
  10. Sadeghi, S. et al. (2021)  Int. J. Biol. Macromol. 191:1175.

Long Name

Keratinocyte Growth Factor

Alternate Names

FGF-7, FGF7, HBGF-7, HBGF7

Entrez Gene IDs

2252 (Human); 403915 (Canine)

Gene Symbol

FGF7

UniProt

P21781.1

Additional KGF/FGF-7 Products

Product Documents for Recombinant Human KGF/FGF-7 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human KGF/FGF-7 Protein, CF

For research use only

Related Research Areas

FGF Family
FGF Ligands
gamma delta T Cells

Customer Reviews for Recombinant Human KGF/FGF-7 Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human KGF/FGF-7 Protein, CF and earn rewards!

Have you used Recombinant Human KGF/FGF-7 Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes